# RYGHT AI | Stripe Sessions Research (SS Database Format)
*Generated: 2026-04-21*

```
=======================================
DATABASE FIELDS: Ryght AI
=======================================

Logo: https://cdn.brandfetch.io/ryght.ai/w/512/h/512/logo
Nombre merchant: Ryght AI

SLIDE 1: PAIN POINTS

Tittle_Pain Point_1: Single Billing Channel
Tittle_Pain Point_2: No Global Pay Options
Tittle_Pain Point_3: Invoice Reconciliation
Tittle_Pain Point_4: Enterprise Procurement Gap
Tittle_Pain Point_5: Subscription Churn Risk

Desc_Pain Point_1: Ryght sells only via Azure Marketplace and direct contracts. Biopharma sponsors in LATAM, SEA, or MENA face procurement friction with limited billing options.
Desc_Pain Point_2: Trials span 60,000+ sites globally, but billing has no local methods. Sponsors in Japan, Brazil, India cannot pay via Konbini, PIX, or UPI.
Desc_Pain Point_3: Azure Marketplace billing consolidates but does not reconcile across currencies or procurement systems, adding overhead for global pharma clients.
Desc_Pain Point_4: Top-20 pharma require local invoicing, POs, and specific payment rails. A single Azure billing path cannot meet diverse procurement policies.
Desc_Pain Point_5: Without retry logic or failover on renewal charges, failed payments on six-figure enterprise contracts risk lost clients and delayed trials.

SLIDE 1: PSP TOPOLOGY

PSP_1: Microsoft Azure Marketplace (primary billing)
PSP_2: Direct invoicing (enterprise contracts)

SLIDE 1: MISSING LOCAL METHODS (BLIND SPOTS)

Local_M_1: SEPA Direct Debit (Europe)
Local_M_2: ACH Direct Debit (US)
Local_M_3: Wire Transfer (global)
Local_M_4: Konbini (Japan)
Local_M_5: Boleto (Brazil)
Local_M_6: UPI (India)
Local_M_7: iDEAL (Netherlands)
Local_M_8: Bancontact (Belgium)
Local_M_9: BLIK (Poland)
Local_M_10: PayNow (Singapore)

SLIDE 2: YUNO CAPABILITIES

Tittle_Yuno_Cap1: Smart Routing
Tittle_Yuno_Cap2: Failover & Retries
Tittle_Yuno_Cap3: Local Payment Methods
Tittle_Yuno_Cap4: Unified Orchestration

Desc_Yuno_Cap1: Route each subscription payment to the optimal processor by sponsor geography, currency, and card issuer. As Ryght scales to hundreds of biopharma clients across 30+ countries, Smart Routing ensures max approval rates on $100K+ annual contracts.
Desc_Yuno_Cap2: When a renewal declines, Yuno cascades to a backup acquirer in milliseconds. Up to 50% recovery on soft declines, protecting enterprise contracts worth months of clinical trial value. Automatic retries across multiple processors.
Desc_Yuno_Cap3: Let biopharma sponsors pay via local methods: SEPA in Europe, ACH in US, UPI in India, Konbini in Japan. One API, 1,000+ methods, removing procurement friction from every market Ryght enters.
Desc_Yuno_Cap4: One dashboard consolidating Azure Marketplace, direct invoicing, and card payments. Real-time visibility into renewal health, payment status per client, geographic revenue, and currency exposure.
```

---

## RESEARCH BACKING | Key Facts for the Meeting

**Ryght AI at a glance:**
- AI-powered clinical research platform for biopharma sponsors and CROs
- Products: RyghtSites.com (free site search), Network Navigator, Feasibility Accelerator, Enterprise Agent Architect, AI Site Twins
- Founded: 2023 (formerly Synthetica Bio)
- Headquarters: Anaheim, California
- ~22 employees
- Total funding: $8.83M (Seed round: $3M led by Foothill Ventures; Accenture Ventures strategic investment in Dec 2025)
- Key investors: Accenture Ventures, AIX Ventures, Top Harvest Capital, Page One Ventures, Foothill Ventures, Iaso Ventures
- Co-founders: Simon Arkell (CEO, serial entrepreneur, 7 venture-backed companies, $100M+ raised), Alex Dickinson (Chairman, ex-Illumina)
- Available on Microsoft Azure Marketplace (since Sep 2025)
- Featured Solution Partner in Microsoft Booth at HLTH 2025
- Claims up to 60% reduction in clinical trial start-up timelines
- AI Site Twins cover 60,000+ global research sites
- Technology partners: Microsoft Azure, Databricks, AWS, Nvidia, Hugging Face
- Key customers/partners: Biorasi, QPS, Kansas University Medical Center, Emory University, University of Adelaide, Avance Clinical, BEK Health, Lucem Health

**Confirmed PSPs & billing infrastructure:**
- Microsoft Azure Marketplace: primary SaaS billing channel for enterprise clients; sponsors can use existing Azure cloud commitments
- Direct enterprise contracts: custom invoicing for large biopharma sponsors
- No consumer-facing payment processing (B2B enterprise SaaS model)
- No payment orchestrator detected
- No Stripe or other PSP references found in public-facing infrastructure

**Business model:**
- Freemium for clinical research sites (free AI-powered feasibility tools)
- Paid SaaS platform for biopharma sponsors and CROs (enterprise pricing, not publicly disclosed)
- Azure Marketplace enables consolidated billing with existing cloud commitments

**Top 5 Markets Gap Analysis:**

MARKET 1: United States (primary market, largest pharma market)
  Currently offer: Azure Marketplace billing, direct invoicing
  Missing: ACH Direct Debit, automated wire transfer, purchase order integration
  US pharma procurement teams require ACH or wire for large SaaS contracts. Credit card limits often fall below enterprise contract values.

MARKET 2: Europe (major pharma hub: UK, Germany, Switzerland, France)
  Currently offer: Azure Marketplace billing
  Missing: SEPA Direct Debit, wire transfer, local invoicing in EUR/GBP/CHF
  European pharma companies (Roche, Novartis, GSK, AstraZeneca) have strict local billing requirements. SEPA DD is standard for recurring B2B SaaS.

MARKET 3: Japan (3rd largest pharma market globally)
  Currently offer: Azure Marketplace billing
  Missing: Konbini, bank transfer (furikomi), JPY invoicing
  Japanese pharma companies require local bank transfer or Konbini payment options. Azure billing in USD creates procurement friction.

MARKET 4: India (growing clinical trial market, 1,800+ active trial sites)
  Currently offer: Azure Marketplace billing
  Missing: UPI, NEFT, INR invoicing
  India is a major clinical trial destination. Local CROs and sponsors expect INR billing and local payment rails.

MARKET 5: Brazil (largest LATAM pharma market)
  Currently offer: Azure Marketplace billing
  Missing: Boleto, PIX, BRL invoicing
  Brazil's clinical trial market is growing rapidly. Local billing requirements include Boleto or PIX for B2B transactions.

**Key meeting angles:**
1. **Early-stage scaling** | Ryght is pre-Series A with 22 employees. Building payment infrastructure now prevents costly retrofitting later as they scale globally.
2. **Accenture backing** | Accenture Ventures investment validates enterprise trajectory. Enterprise biopharma clients will demand flexible billing as deal sizes grow.
3. **60,000+ global sites** | Platform covers sites worldwide but billing is US-centric. Payment localization matches the global scope of clinical trials.
4. **Azure Marketplace dependency** | Single billing channel creates risk. Multi-provider payment stack adds resilience and flexibility.
5. **High-value contracts** | Enterprise biopharma SaaS deals are six to seven figures. Every failed payment on a renewal represents significant revenue and trial continuity risk.
6. **Competitive landscape** | Medidata (Dassault), Veeva, Oracle Health Sciences all offer localized enterprise billing. Ryght needs payment parity to compete for global pharma budgets.

**Sources:**
- [Ryght AI Homepage](https://www.ryght.ai/)
- [Ryght AI About Us](https://www.ryght.ai/about-us)
- [Ryght AI Azure Marketplace Announcement](https://www.prnewswire.com/news-releases/ryght-ais-advanced-clinical-research-platform-now-available-in-microsoft-azure-marketplace-302563513.html)
- [Accenture Invests in Ryght AI](https://newsroom.accenture.com/news/2025/accenture-invests-in-ryght-ai-to-help-life-sciences-companies-transform-clinical-research-with-agentic-ai)
- [Ryght AI HLTH 2025](https://www.prnewswire.com/news-releases/ryght-ai-to-showcase-ai-powered-clinical-research-platform-as-featured-solution-partner-in-microsoft-booth-at-hlth-2025-302574908.html)
- [Ryght AI Scientific Advisory Board](https://www.prnewswire.com/news-releases/ryght-ai-assembles-renowned-medical-leaders-to-guide-next-phase-of-clinical-trial-ai-innovation-302576488.html)
- [Ryght AI Seed Round](https://www.thesaasnews.com/news/ryght-ai-raises-3-million-in-seed-round)
- [Ryght AI Crunchbase](https://www.crunchbase.com/organization/synthetica-bio)
- [Ryght AI CBInsights](https://www.cbinsights.com/company/ryght)
- [Ryght AI Azure Marketplace Listing](https://marketplace.microsoft.com/en-us/product/saas/ryghtai.d1a18dd0-55de-4c06-92e5-3ebfc8bb8af7)
